Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study

AIM: To assesses the safety and efficacy of Aspergillus niger prolyl endoprotease (AN-PEP) to mitigate the immunogenic effects of gluten in celiac patients. METHODS: Patients with initial diagnosis of celiac disease as confirmed by positive serology with subtotal or total villous atrophy on duodenal...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tack, Greetje J, van de Water, Jolanda MW, Bruins, Maaike J, Kooy-Winkelaar, Engelina MC, van Bergen, Jeroen, Bonnet, Petra, Vreugdenhil, Anita CE, Korponay-Szabo, Ilma, Edens, Luppo, von Blomberg, B Mary E, Schreurs, Marco WJ, Mulder, Chris J, Koning, Frits
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Co., Limited 2013
Sujets:
Brief Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3793137/
https://ncbi.nlm.nih.gov/pubmed/24124328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i35.5837
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires